Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02366312
Title A Phase 2, Single-center, Single-arm, Open Label Trial of Vismodegib in Patients With Keratocystic Odontogenic Tumors
Acronym KCOT
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors The Bluestone Center for Clinical Research
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.